|
|
|
|
|
|
Lonza Group is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows:
- exclusive syntheses and bio-pharmaceutical products (48.2%): exclusive syntheses, microbiological fermentation products , mammalian cell cultures, etc.;
- fine organic and performance chemical products (43.9%): for food products, hygiene products, beauty products, water treatment and wood care products, etc.;
- bioscience products (7.5%);
- other (0.4%).
Net sales break down geographically as follows: Switzerland (13.9%), Europe (25.1%), North America (44.6%) and other (16.4%).
| |
| Surperformance© rating of Lonza Group AG | |
|
|
Overall rating |
In sector |
In country |
| Trading Rating |
|
|
|
| Investor Rating |
|
|
|
| Growth (Revenue) |
|
|
|
| Valuation |
|
|
|
| Finances |
|
|
|
| Profitability |
|
|
|
| Earnings quality |
|
|
|
| Business Predictability |
|
|
|
| PER |
|
|
|
| Potential |
|
|
|
| Yield |
|
|
|
| Consensus |
|
|
|
| 7 days EPS revision |
|
|
|
| 4 months EPS revision |
|
|
|
| 1 year EPS revision |
|
|
|
| 4 months Revenue revision |
|
|
|
| 1 year Revenue revision |
|
|
|
| |
| |
|
|
Data source : © 2013 Thomson Reuters |
|
Ratings : © 2013 Surperformance |
|
|
|
|
|
| - Franklin Templeton Companies LLC |
9,68% |
| - Grupo Plafin |
8,17% |
| - Company-owned shares |
5,28% |
| - Marsico Capital Management |
4,89% |
|
|
|
|
- Chief Financial Officer : Toralf Haag |
- Investor Relations : Alexandre Pasini |
- Chief Executive Officer : Stefan Borgas |
- Communications : Dominik Werner |
|
|
| Company contact information |
|
38 Münchensteinerstrasse CH-4002 Basel Switzerland
Phone : +41 61 316 81 11 Fax : +41 61 316 91 11 Internet : http://www.lonzagroup.com
|
|
|
|
- SIX Swiss Exchange - Main Standard |
|
|
|
|
| - ISIN Code : |
CH0013841017 |
| - Bloomberg Code : |
LONN:VX |
| - Reuters Code : |
LONN.VX |
| - Datastream Code : |
S:LONN |
|
Financial data source : © 2013 Cofisem |
|
|